A New Drug Puts Cancer Cells Permanently to 'SLEEP'

Scientist discovered anti-cancer drug without the usual side effects of conventional cancer treatments.

Research up to now has proven progress in delaying cancer relapse in addition to treating some forms of cancer.

The technique of preventing the growth of tumors occurs without damaging any cell's DNA, which takes place in traditional treatments including chemotherapy and radiotherapy.

The future of cancer therapy might be is to have directed and focused treatments so as to work on specific patient groups. A new kind of approach to cancer therapy that is preventing cancer cells from growing, however, leaving the normal cells especially unaffected and that's by harnessing the body's normal defenses against unrestricted growth.

The development of the drug is at a pre-clinical stage. The research indicates that by targeting certain proteins recognized to play the primary function in the development of cancer, doctors can essentially prevent the disease.

These proteins are known as KAT6A and KAT6B and they're proteins that affect certain genes most commonly observed in cancers. The disease-causing protein that has been targeted has actually not been able to be targeted before with a small-molecule potential drug. Researchers developed a small molecule that inhibits these proteins.

The way that those epigenetic drugs work especially this drug is that it freezes the cell, however, does not kill it off. In case you are at a late stage disease and have lots of tumors in your body, we obviously need to get rid of that first before seeking to prevent the cells from growing. This drug could be definitely beneficial after the usage of initial therapy that gets rid of the original tumor mass and we might use that new type of epigenetic drug to prevent any tumors from developing back, that's a truly beneficial concept and idea.